Jennison Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-86,670
| Closed | -$14.7M | – | 633 |
|
|
2023
Q3 | $14.7M | Buy |
86,670
+40,880
| +89% | +$6.91M | 0.01% | 340 |
|
|
2023
Q2 | $9.93M | Buy |
+45,790
| New | +$9.93M | 0.01% | 380 |
|
|
2022
Q2 | – | Sell |
-273,540
| Closed | -$34.7M | – | 715 |
|
|
2022
Q1 | $34.7M | Buy |
273,540
+93,290
| +52% | +$11.8M | 0.03% | 279 |
|
|
2021
Q4 | $23.6M | Buy |
180,250
+91,909
| +104% | +$12M | 0.02% | 336 |
|
|
2021
Q3 | $10.8M | Buy |
+88,341
| New | +$10.8M | 0.01% | 443 |
|